Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists listen to your heartbeat to decode a diabetes Drug's hidden benefit

NCT ID NCT07471802

Summary

This study aims to understand how a common diabetes medication (SGLT2 inhibitors) affects the body's automatic nervous system in people with type 2 diabetes who also have heart failure or chronic kidney disease. Researchers will monitor 150 participants by analyzing their heart rate patterns over 24 hours using a portable device (Holter monitor) before and after starting the medication. The goal is to gather knowledge about how this drug helps protect the heart and kidneys beyond just lowering blood sugar.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.